General Information
Cerebrex Capital Ltd (Company Registration: 09901249 | UK Financial Services Licence) is the issuer of investment products offered through this website. For further information about any of our funds, or to request a free copy of the relevant Product Disclosure Statement (PDS) or Target Market Determination (TMD) (where applicable), please contact our team directly.
All investment products are subject to risk, including the potential for delays in withdrawals, loss of income, and the loss of capital. Neither Cerebrex Capital, nor any related party, guarantees the performance of any investment or the return of your capital.
Important Financial Advice Warning
The information provided on the Cerebrex Capital website is general in nature and does not constitute financial product advice. It has been prepared without considering your personal objectives, financial circumstances, or needs.
Before acting on any information, you should assess its appropriateness to your situation, and read the relevant PDS and TMD. We strongly recommend you seek independent financial, tax, and legal advice before making an investment decision.
Current PDSs and TMDs are available free of charge via this website, through your financial adviser, or by contacting our Client Services team.
Unless explicitly stated otherwise, all content on this website is provided by Cerebrex Capital Ltd as the issuer of the applicable product.
Fees, Remuneration & Conflicts of Interest
If you invest in a product or service through Cerebrex Capital, we may receive fees and other benefits. These will be disclosed in the relevant PDS or in any service agreement you enter into. They may include:
Our staff, including Directors, are remunerated via salary and may also receive performance-based bonuses or non-monetary incentives. Director fees may also apply, but these payments are made by Cerebrex Capital and do not affect your investment costs.
You may engage a financial adviser to assist you in evaluating or acquiring our products. Cerebrex Capital does not pay any commissions or benefits to your adviser. Any fees payable to your adviser are a separate arrangement between you and your adviser.
For more details, please refer to our Financial Services Guide (FSG) available on our website.
Changes to Products
Cerebrex Capital reserves the right to withdraw, amend, or suspend the availability of any investment product at any time and without notice. Associated information may also be updated or removed at our discretion.
Capital Risk & No Guarantees
Investments carry risk. Cerebrex Capital and its related entities, custodians, or investment managers do not guarantee:
All financial products carry inherent risk, as outlined in each product’s disclosure documents.
Forward-Looking Statements
Content on this website may contain forward-looking statements, which reflect our current expectations about future events and performance. These statements often use words such as “expect,” “intend,” “may,” “forecast,” or “estimate.”
Such statements are not guarantees of future outcomes and are subject to change due to various risks, uncertainties, or market conditions outside our control. Actual results may differ materially. Cerebrex Capital is not obligated to update these statements and makes no warranties regarding their accuracy or reliability.
Forward-looking statements should not be relied upon as advice or as the basis for investment decisions.
Hypothetical Examples & Illustrations
Any hypothetical returns, case studies, or illustrative examples on the Cerebrex Capital website are provided purely for explanatory purposes. These do not represent actual outcomes and should not be relied on when making investment decisions, as your personal situation will influence your results.
Past Performance
Past performance is not a reliable indicator of future performance. Any references to past returns are intended for general illustrative purposes only and do not constitute a guarantee or forecast.
Let me know when you’re ready to proceed with the next section or if you’d like this version exported as a PDF or Word document for internal use or compliance review.
Cerebrex Capital Ltd
International House
12 Constance Street
London, E16 2DQ
UK
Email: info@cerebrexcapital.com
Phone: +44 20 7123 4567
LEI:
5493005UD8CQHFHWIH70
Company Registration: 09901249 (Companies House - England
and Wales)